Full text is available at the source.
Derailed peripheral circadian genes in polycystic ovary syndrome patients alters peripheral conversion of androgens synthesis
Jun 21, 2022Human reproduction (Oxford, England)
Disrupted daily rhythm genes in the body may change how androgens are made in polycystic ovary syndrome
AI simplified
Abstract
Aberrant expression of circadian clock genes was observed in 101 patients with polycystic ovary syndrome (PCOS).
- Core clock genes including CLOCK and BMAL1 showed significant reductions in PCOS patients.
- Negative feedback loop genes such as CRY1 and PER2 were upregulated in PCOS subjects.
- Increased mRNA levels of steroidogenic enzymes were found in PBMCs of PCOS women.
- Knockdown of CLOCK/BMAL1 in PBMCs led to reduced estradiol and increased dihydrotestosterone production.
- Altered expression patterns of clock genes were associated with phenotype A of PCOS.
- DHEA-treated PCOS mice exhibited reduced expression of ovarian core clock genes compared to controls.
AI simplified
STUDY QUESTION: Do circadian genes exhibit an altered profile in peripheral blood mononuclear cells (PBMCs) of polycystic ovary syndrome (PCOS) patients and do they have a potential role in androgen excess?
SUMMARY ANSWER: Our findings revealed that an impaired circadian clock could hamper the regulation of peripheral steroid metabolism in PCOS women.
WHAT IS KNOWN ALREADY: PCOS patients exhibit features of metabolic syndrome. Circadian rhythm disruption is involved in the development of metabolic diseases and subfertility. An association between shift work and the incidence of PCOS in females was recently reported.
STUDY DESIGN, SIZE, DURATION: This is a retrospective case-referent study in which peripheral blood samples were obtained from 101 control and 101 PCOS subjects. PCOS diagnoses were based on Rotterdam Consensus criteria.
PARTICIPANTS/MATERIALS, SETTING, METHODS: This study comprised 101 women with PCOS and 101 control volunteers, as well as Swiss albino mice treated with dehydroepiandrosterone (DHEA) to induce PCOS development. Gene expression analyses of circadian and steroidogenesis genes in human PBMC and mice ovaries and blood were executed by quantitative real-time PCR.
MAIN RESULTS AND THE ROLE OF CHANCE: We observed aberrant expression of peripheral circadian clock genes in PCOS, with a significant reduction in the core clock genes, circadian locomotor output cycles kaput (CLOCK) (P ≤ 0.00001), brain and muscle ARNT-like 1 (BMAL1) (P ≤ 0.00001) and NPAS2 (P ≤ 0.001), and upregulation of their negative feedback loop genes, CRY1 (P ≤ 0.00003), CRY2 (P ≤ 0.00006), PER1 (P ≤ 0.003), PER2 (P ≤ 0.002), DEC1 (P ≤ 0.0001) and DEC2 (P ≤ 0.00005). Transcript levels of an additional feedback loop regulating BMAL1 showed varied expression, with reduced RORA (P ≤ 0.008) and increased NR1D1 (P ≤ 0.02) in PCOS patients in comparison with the control group. We also demonstrated the expression pattern of clock genes in PBMCs of PCOS women at three different time points. PCOS patients also exhibited increased mRNA levels of steroidogenic enzymes like StAR (P ≤ 0.0005), CYP17A1 (P ≤ 0.005), SRD5A1 (P ≤ 0.00006) and SRD5A2 (P ≤ 0.009). Knockdown of CLOCK/BMAL1 in PBMCs resulted in a significant reduction in estradiol production, by reducing CYP19A1 and a significant increase in dihydrotestosterone production, by upregulating SRD5A1 and SRD5A2 in PBMCs. Our data also showed that CYP17A1 as a direct CLOCK-BMAL1 target in PBMCs. Phenotypic classification of PCOS subgroups showed a higher variation in expression of clock genes and steroidogenesis genes with phenotype A of PCOS. In alignment with the above results, altered expression of ovarian core clock genes (Clock, Bmal1 and Per2) was found in DHEA-treated PCOS mice. The expression of peripheral blood core clock genes in DHEA-induced PCOS mice was less robust and showed a loss of periodicity in comparison with that of control mice.
LARGE SCALE DATA: N/A.
LIMITATIONS, REASONS FOR CAUTION: We could not evaluate the circadian oscillation of clock genes and clock-controlled genes over a 24-h period in the peripheral blood of control versus PCOS subjects. Additionally, circadian genes in the ovaries of PCOS women could not be evaluated due to limitations in sample availability, hence we employed the androgen excess mouse model of PCOS for ovarian circadian assessment. Clock genes were assessed in the whole ovary of the androgen excess mouse model of PCOS rather than in granulosa cells, which is another limitation of the present work.
WIDER IMPLICATIONS OF THE FINDINGS: Our observations suggest that the biological clock is one of the contributing factors in androgen excess in PCOS, owing to its potential role in modulating peripheral androgen metabolism. Considering the increasing prevalence of PCOS and the rising frequency of delayed circadian rhythms and insufficient sleep among women, our study emphasizes the potential in modulating circadian rhythm as an important strategy in PCOS management, and further research on this aspect is highly warranted.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the RGCB-DBT Core Funds and a grant (#BT/PR29996/MED/97/472/2020) from the Department of Biotechnology (DBT), India, to M.L. B.S.J. was supported by a DST/INSPIRE Fellowship/2015/IF150361 and M.B.K. was supported by the Research Fellowship from Council of Scientific & Industrial Research (CSIR) (10.2(5)/2007(ii).E.U.II). The authors declare no competing interests.
TRIAL REGISTRATION NUMBER: N/A.
Related papers
Apr '22
Genes linked to polycystic ovary syndrome are controlled by a growth factor in the developing cow ovary
top 5% journal
cited by 20 papers
research support, non-u.s. gov't
Nov '19
Control and communication of anti-Müllerian hormone in ovarian cells and its link to polycystic ovary syndrome
top 5% journal
cited by 19 papers
research support, non-u.s. gov't
Nov '19
Guidelines for studying the causes and traits of polycystic ovary syndrome
top 5% journal
cited by 89 papers
research support, non-u.s. gov't
Apr '22
How Energy-Related AMPK Signaling May Link High Male Hormones to Female Infertility
top 5% journal
cited by 28 papers
research support, non-u.s. gov't
Aug '15
Androgen levels in women with different ovarian problems linked to heart and metabolism health
top 5% journal
cited by 67 papers
research support, non-u.s. gov't
Apr '22
Gene activity in ovarian support cells and blood immune cells in women with PCOS compared to young women with poor and normal ovarian response
top 5% journal
cited by 24 papers
research support, non-u.s. gov't
Sep '16
Changes in daily rhythm and hormone-making genes in the human ovary after testosterone exposure
top 20% journal
cited by 26 papers
journal article
Mar '24
Androgen may cause iron-related cell damage in the ovaries linked to PCOS
top 5% journal
cited by 42 papers
journal article
Mar '20
Changing the body’s internal clock to treat insulin resistance and high male hormone levels caused by constant darkness in polycystic ovary syndrome
top 5% journal
cited by 62 papers
research support, n.i.h., extramural
Mar '17
Vitamin D3’s effects on hormone production in egg-supporting cells in a mouse model of polycystic ovary syndrome
top 30% journal
cited by 48 papers
journal article